Samuel George A. III
SEC insider (Form 3/4/5 filer). CIK 0001878732. General Counsel and Secretary at Lineage Cell Therapeutics, Inc. (LCTX). 9 reported Form 4/5 transactions since Sep 2024; latest on Mar 5, 2026. Located in CARLSBAD, CA.
Companies Samuel George A. III has filed insider reports for
- Lineage Cell Therapeutics, Inc. (LCTX): Officer, General Counsel and Secretary
Samuel George A. III
CIK: 0001878732
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Lineage Cell Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Mar 5, 2026LCTX
Lineage Cell Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
900K shares- - Feb 11, 2026LCTX
Lineage Cell Therapeutics, Inc.
ExerciseDirect6.1K shares- - Feb 11, 2026LCTX
Lineage Cell Therapeutics, Inc.
Tax PaymentDirect2.5K shares at avg. $1.80$5K - Dec 19, 2025LCTX
Lineage Cell Therapeutics, Inc.
AwardDirect1.7K shares- - Dec 19, 2025LCTX
Lineage Cell Therapeutics, Inc.
Tax PaymentDirect65 shares at avg. $1.68$109.2 - Mar 10, 2025LCTX
Lineage Cell Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
750K shares- - Feb 11, 2025LCTX
Lineage Cell Therapeutics, Inc.
Tax PaymentDirect2.4K shares at avg. $0.65$2K - Feb 11, 2025LCTX
Lineage Cell Therapeutics, Inc.
ExerciseDirect6.1K shares- - Nov 26, 2024LCTX
Lineage Cell Therapeutics, Inc.
PurchaseDirect15K shares at avg. $0.60$9K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 5, 2026 | LCTX Lineage Cell Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 900,000 | - | - | Direct |
| Feb 11, 2026 | LCTX Lineage Cell Therapeutics, Inc. | Exercise | 6,075 | - | $0 | Direct |
| Feb 11, 2026 | LCTX Lineage Cell Therapeutics, Inc. | Tax Payment | 2,502 | $1.80 | $4,504 | Direct |
| Dec 19, 2025 | LCTX Lineage Cell Therapeutics, Inc. | Award | 1,735 | - | - | Direct |
| Dec 19, 2025 | LCTX Lineage Cell Therapeutics, Inc. | Tax Payment | 65 | $1.68 | $109 | Direct |
| Mar 10, 2025 | LCTX Lineage Cell Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 750,000 | - | - | Direct |
| Feb 11, 2025 | LCTX Lineage Cell Therapeutics, Inc. | Tax Payment | 2,440 | $0.65 | $1,586 | Direct |
| Feb 11, 2025 | LCTX Lineage Cell Therapeutics, Inc. | Exercise | 6,076 | - | - | Direct |
| Nov 26, 2024 | LCTX Lineage Cell Therapeutics, Inc. | Purchase | 15,000 | $0.60 | $9,000 | Direct |
1-9 of 9 transactions